Sulfasalazine monitoring — GPhC CRA MCQ

Instant feedback + full explanation. One question, done properly.

ModerateMusculoskeletal TherapeuticsSulfasalazine monitoringGPhC CRA

A patient newly started on sulfasalazine for inflammatory arthritis asks why frequent blood tests are arranged. What monitoring is required?

Educational content. Not a substitute for clinical judgement or local policy.

Reveal the answer and explanation

Correct answer: D — Full blood count and liver function monitoring

Sulfasalazine can cause blood dyscrasias and hepatotoxicity. Full blood count and liver function monitoring are required, particularly early in treatment. The other options either delay appropriate care, use an unsuitable medicine, or miss the main safety issue.

Reference: BNF